世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 Global Precision Diagnostics & Medicine Market Size Study & Forecast by Type (Genetic Tests, Esoteric Tests, and Others) and Application (Oncology, Cardiovascular, Neurology, and Others) and Regional Forecasts 2022-2032
The Global Precision Diagnostics & Medicine Market, valued at approximately USD 75.85 billion in 2024, is poised to surge with a compound annual growth rate (CAGR) of 13.10% from 2025 through 2035.... もっと見る
SummaryThe Global Precision Diagnostics & Medicine Market, valued at approximately USD 75.85 billion in 2024, is poised to surge with a compound annual growth rate (CAGR) of 13.10% from 2025 through 2035. Precision diagnostics and medicine encompass a transformative approach within healthcare that leverages advanced testing techniques—ranging from genetic to esoteric tests—to tailor therapeutic interventions precisely to patient profiles. This evolution facilitates early detection, personalized treatment plans, and improved patient outcomes, thereby driving the momentum of the market. The growing prevalence of chronic diseases, rapid advancements in molecular diagnostics, and increased healthcare expenditure across developed and emerging economies collectively bolster market expansion.This escalating demand for precision diagnostics is closely tied to breakthroughs in genomic sequencing and biomarker identification, which enable clinicians to pinpoint disease etiologies with unprecedented accuracy. Oncology remains the foremost application segment, as the integration of precision medicine significantly refines cancer diagnosis and treatment paradigms. Meanwhile, cardiovascular and neurological disorders also present robust avenues for growth, propelled by increasing incidence rates and the urgent need for personalized healthcare solutions. Furthermore, expanding end-user adoption—spanning hospitals, clinical laboratories, and emerging homecare diagnostic platforms—reflects an evolving landscape where accessibility and patient-centric care remain paramount. Nevertheless, challenges such as regulatory complexities and high costs may temper market acceleration during the forecast horizon. Regionally, North America dominates the precision diagnostics and medicine arena, buoyed by its sophisticated healthcare infrastructure, substantial R&D investments, and a strong presence of key market players. The United States, in particular, leads in adopting cutting-edge diagnostic technologies and personalized therapies, supported by favorable reimbursement policies and robust regulatory frameworks. Europe follows closely, driven by rising healthcare awareness and governmental support across countries like Germany, the UK, and France. However, Asia Pacific is anticipated to witness the fastest growth, fueled by burgeoning healthcare infrastructure, rising disposable incomes, and increasing disease burden in populous countries such as China and India. Additionally, strategic collaborations and government initiatives aimed at advancing precision medicine are catalyzing market expansion in this region. Latin America and the Middle East & Africa, although comparatively nascent, are progressively investing in precision healthcare capabilities, offering promising prospects for future growth. Major market players included in this report are: • Bayer AG • Thermo Fisher Scientific Inc. • Illumina, Inc. • F. Hoffmann-La Roche Ltd. • Abbott Laboratories • Agilent Technologies, Inc. • Becton, Dickinson and Company • Siemens Healthineers AG • PerkinElmer, Inc. • QIAGEN N.V. • Charles River Laboratories International, Inc. • Exact Sciences Corporation • Invitae Corporation • Guardant Health, Inc. • BD Diagnostics Global Precision Diagnostics & Medicine Market Report Scope: • Historical Data – 2023, 2024 • Base Year for Estimation – 2024 • Forecast Period – 2025-2035 • Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends • Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa • Customization Scope – Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope* The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below: By Type: • Genetic Tests • Esoteric Tests • Others By Application: • Oncology • Cardiovascular • Neurology • Others By End User: • Hospitals • Clinical Laboratories • Homecare By Region: North America • U.S. • Canada Europe • UK • Germany • France • Spain • Italy • Rest of Europe (ROE) Asia Pacific • China • India • Japan • Australia • South Korea • Rest of Asia Pacific (RoAPAC) Latin America • Brazil • Mexico Middle East & Africa • UAE • Saudi Arabia • South Africa • Rest of Middle East & Africa Key Takeaways: • Market Estimates & Forecast for 10 years from 2025 to 2035. • Annualized revenues and regional level analysis for each market segment. • Detailed analysis of geographical landscape with Country level analysis of major regions. • Competitive landscape with information on major players in the market. • Analysis of key business strategies and recommendations on future market approach. • Analysis of competitive structure of the market. • Demand side and supply side analysis of the market. Table of ContentsTable of ContentsChapter 1. Global Precision Diagnostics & Medicine Market Report Scope & Methodology 1.1. Research Objective 1.2. Research Methodology 1.2.1. Forecast Model 1.2.2. Desk Research 1.2.3. Top Down and Bottom-Up Approach 1.3. Research Attributes 1.4. Scope of the Study 1.4.1. Market Definition 1.4.2. Market Segmentation 1.5. Research Assumption 1.5.1. Inclusion & Exclusion 1.5.2. Limitations 1.5.3. Years Considered for the Study Chapter 2. Executive Summary 2.1. CEO/CXO Standpoint 2.2. Strategic Insights 2.3. ESG Analysis 2.4. Key Findings Chapter 3. Global Precision Diagnostics & Medicine Market Forces Analysis 3.1. Market Forces Shaping The Global Precision Diagnostics & Medicine Market (2024-2035) 3.2. Drivers 3.2.1. Growing Prevalence of Chronic Diseases 3.2.2. Advancements in Molecular Diagnostics and Genomic Sequencing 3.3. Restraints 3.3.1. Regulatory Complexities and Approvals 3.3.2. High Cost of Precision Diagnostic Tests and Therapies 3.4. Opportunities 3.4.1. Expansion of Homecare Diagnostic Platforms 3.4.2. Increasing Healthcare Expenditure in Emerging Economies Chapter 4. Global Precision Diagnostics & Medicine Industry Analysis 4.1. Porter’s 5 Forces Model 4.1.1. Bargaining Power of Buyer 4.1.2. Bargaining Power of Supplier 4.1.3. Threat of New Entrants 4.1.4. Threat of Substitutes 4.1.5. Competitive Rivalry 4.2. Porter’s 5 Force Forecast Model (2024-2035) 4.3. PESTEL Analysis 4.3.1. Political 4.3.2. Economical 4.3.3. Social 4.3.4. Technological 4.3.5. Environmental 4.3.6. Legal 4.4. Top Investment Opportunities 4.5. Top Winning Strategies (2025) 4.6. Market Share Analysis (2024-2025) 4.7. Global Pricing Analysis And Trends 2025 4.8. Analyst Recommendation & Conclusion Chapter 5. Global Precision Diagnostics & Medicine Market Size & Forecasts by Type 2025-2035 5.1. Market Overview 5.2. Global Precision Diagnostics & Medicine Market Performance - Potential Analysis (2025) 5.3. Genetic Tests 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 5.3.2. Market Size Analysis, by Region, 2025-2035 5.4. Esoteric Tests 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 5.4.2. Market Size Analysis, by Region, 2025-2035 5.5. Others 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 5.5.2. Market Size Analysis, by Region, 2025-2035 Chapter 6. Global Precision Diagnostics & Medicine Market Size & Forecasts by Application 2025–2035 6.1. Market Overview 6.2. Global Precision Diagnostics & Medicine Market Performance - Potential Analysis (2025) 6.3. Oncology 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 6.3.2. Market Size Analysis, by Region, 2025-2035 6.4. Cardiovascular 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 6.4.2. Market Size Analysis, by Region, 2025-2035 6.5. Neurology 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 6.5.2. Market Size Analysis, by Region, 2025-2035 6.6. Others 6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035 6.6.2. Market Size Analysis, by Region, 2025-2035 Chapter 7. Global Precision Diagnostics & Medicine Market Size & Forecasts by Region 2025–2035 7.1. Precision Diagnostics & Medicine Market, Regional Market Snapshot 7.2. Top Leading & Emerging Countries 7.3. North America Precision Diagnostics & Medicine Market 7.3.1. U.S. Precision Diagnostics & Medicine Market 7.3.1.1. Type Breakdown Size & Forecasts, 2025-2035 7.3.1.2. Application Breakdown Size & Forecasts, 2025-2035 7.3.2. Canada Precision Diagnostics & Medicine Market 7.3.2.1. Type Breakdown Size & Forecasts, 2025-2035 7.3.2.2. Application Breakdown Size & Forecasts, 2025-2035 7.4. Europe Precision Diagnostics & Medicine Market 7.4.1. UK Precision Diagnostics & Medicine Market 7.4.1.1. Type Breakdown Size & Forecasts, 2025-2035 7.4.1.2. Application Breakdown Size & Forecasts, 2025-2035 7.4.2. Germany Precision Diagnostics & Medicine Market 7.4.2.1. Type Breakdown Size & Forecasts, 2025-2035 7.4.2.2. Application Breakdown Size & Forecasts, 2025-2035 7.4.3. France Precision Diagnostics & Medicine Market 7.4.3.1. Type Breakdown Size & Forecasts, 2025-2035 7.4.3.2. Application Breakdown Size & Forecasts, 2025-2035 7.4.4. Spain Precision Diagnostics & Medicine Market 7.4.4.1. Type Breakdown Size & Forecasts, 2025-2035 7.4.4.2. Application Breakdown Size & Forecasts, 2025-2035 7.4.5. Italy Precision Diagnostics & Medicine Market 7.4.5.1. Type Breakdown Size & Forecasts, 2025-2035 7.4.5.2. Application Breakdown Size & Forecasts, 2025-2035 7.4.6. Rest of Europe Precision Diagnostics & Medicine Market 7.4.6.1. Type Breakdown Size & Forecasts, 2025-2035 7.4.6.2. Application Breakdown Size & Forecasts, 2025-2035 7.5. Asia Pacific Precision Diagnostics & Medicine Market 7.5.1. China Precision Diagnostics & Medicine Market 7.5.1.1. Type Breakdown Size & Forecasts, 2025-2035 7.5.1.2. Application Breakdown Size & Forecasts, 2025-2035 7.5.2. India Precision Diagnostics & Medicine Market 7.5.2.1. Type Breakdown Size & Forecasts, 2025-2035 7.5.2.2. Application Breakdown Size & Forecasts, 2025-2035 7.5.3. Japan Precision Diagnostics & Medicine Market 7.5.3.1. Type Breakdown Size & Forecasts, 2025-2035 7.5.3.2. Application Breakdown Size & Forecasts, 2025-2035 7.5.4. Australia Precision Diagnostics & Medicine Market 7.5.4.1. Type Breakdown Size & Forecasts, 2025-2035 7.5.4.2. Application Breakdown Size & Forecasts, 2025-2035 7.5.5. South Korea Precision Diagnostics & Medicine Market 7.5.5.1. Type Breakdown Size & Forecasts, 2025-2035 7.5.5.2. Application Breakdown Size & Forecasts, 2025-2035 7.5.6. Rest of Asia Pacific Precision Diagnostics & Medicine Market 7.5.6.1. Type Breakdown Size & Forecasts, 2025-2035 7.5.6.2. Application Breakdown Size & Forecasts, 2025-2035 7.6. Latin America Precision Diagnostics & Medicine Market 7.6.1. Brazil Precision Diagnostics & Medicine Market 7.6.1.1. Type Breakdown Size & Forecasts, 2025-2035 7.6.1.2. Application Breakdown Size & Forecasts, 2025-2035 7.6.2. Mexico Precision Diagnostics & Medicine Market 7.6.2.1. Type Breakdown Size & Forecasts, 2025-2035 7.6.2.2. Application Breakdown Size & Forecasts, 2025-2035 7.7. Middle East and Africa Precision Diagnostics & Medicine Market 7.7.1. UAE Precision Diagnostics & Medicine Market 7.7.1.1. Type Breakdown Size & Forecasts, 2025-2035 7.7.1.2. Application Breakdown Size & Forecasts, 2025-2035 7.7.2. Saudi Arabia (KSA) Precision Diagnostics & Medicine Market 7.7.2.1. Type Breakdown Size & Forecasts, 2025-2035 7.7.2.2. Application Breakdown Size & Forecasts, 2025-2035 7.7.3. South Africa Precision Diagnostics & Medicine Market 7.7.3.1. Type Breakdown Size & Forecasts, 2025-2035 7.7.3.2. Application Breakdown Size & Forecasts, 2025-2035 7.7.4. Rest of Middle East & Africa Precision Diagnostics & Medicine Market 7.7.4.1. Type Breakdown Size & Forecasts, 2025-2035 7.7.4.2. Application Breakdown Size & Forecasts, 2025-2035 Chapter 8. Competitive Intelligence 8.1. Top Market Strategies 8.2. Bayer AG 8.2.1. Company Overview 8.2.2. Key Executives 8.2.3. Company Snapshot 8.2.4. Financial Performance (Subject to Data Availability) 8.2.5. Product/Services Port 8.2.6. Recent Development 8.2.7. Market Strategies 8.2.8. SWOT Analysis 8.3. Thermo Fisher Scientific Inc. 8.4. Illumina, Inc. 8.5. F. Hoffmann-La Roche Ltd. 8.6. Abbott Laboratories 8.7. Agilent Technologies, Inc. 8.8. Becton, Dickinson and Company 8.9. Siemens Healthineers AG 8.10. PerkinElmer, Inc. 8.11. QIAGEN N.V. 8.12. Charles River Laboratories International, Inc. 8.13. Exact Sciences Corporation 8.14. Invitae Corporation 8.15. Guardant Health, Inc. 8.16. BD Diagnostics
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医薬）の最新刊レポート
Bizwit Research & Consulting LLP社の 医薬品分野 での最新刊レポート
本レポートと同じKEY WORD（diagnostics）の最新刊レポート
よくあるご質問Bizwit Research & Consulting LLP社はどのような調査会社ですか?Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
